DK0811008T3 - Bicycliske benzazepinderivater som vasopressinantagonister - Google Patents

Bicycliske benzazepinderivater som vasopressinantagonister

Info

Publication number
DK0811008T3
DK0811008T3 DK96903711T DK96903711T DK0811008T3 DK 0811008 T3 DK0811008 T3 DK 0811008T3 DK 96903711 T DK96903711 T DK 96903711T DK 96903711 T DK96903711 T DK 96903711T DK 0811008 T3 DK0811008 T3 DK 0811008T3
Authority
DK
Denmark
Prior art keywords
vasopressin antagonists
benzazepine derivatives
bicyclic
bicyclic benzazepine
derivatives
Prior art date
Application number
DK96903711T
Other languages
Danish (da)
English (en)
Inventor
Jay Donald Albright
Santos Efren Guillermo Delos
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of DK0811008T3 publication Critical patent/DK0811008T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK96903711T 1995-01-17 1996-01-16 Bicycliske benzazepinderivater som vasopressinantagonister DK0811008T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/373,839 US5696112A (en) 1995-01-17 1995-01-17 Fused heterocyclic azepines as vasopressin antagonists
PCT/US1996/001096 WO1996022294A1 (en) 1995-01-17 1996-01-16 Bicyclic benzazepine derivatives as vasopressin antagonists

Publications (1)

Publication Number Publication Date
DK0811008T3 true DK0811008T3 (da) 2004-01-26

Family

ID=23474102

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96903711T DK0811008T3 (da) 1995-01-17 1996-01-16 Bicycliske benzazepinderivater som vasopressinantagonister

Country Status (23)

Country Link
US (2) US5696112A (de)
EP (1) EP0811008B1 (de)
JP (1) JPH10512572A (de)
KR (1) KR19980703098A (de)
CN (1) CN1177356A (de)
AR (1) AR010195A1 (de)
AT (1) ATE251166T1 (de)
AU (1) AU716008B2 (de)
BR (1) BR9607153A (de)
CA (1) CA2210571A1 (de)
CZ (1) CZ224697A3 (de)
DE (1) DE69630209T2 (de)
DK (1) DK0811008T3 (de)
EA (1) EA001427B1 (de)
ES (1) ES2207672T3 (de)
HU (1) HUP9800466A3 (de)
IL (1) IL116776A (de)
MX (1) MX9705312A (de)
NZ (1) NZ302119A (de)
PT (1) PT811008E (de)
TW (1) TW342385B (de)
WO (1) WO1996022294A1 (de)
ZA (1) ZA96298B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997017349A1 (en) * 1995-11-09 1997-05-15 Japan Tobacco Inc. Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
US6235900B1 (en) 1999-02-04 2001-05-22 American Home Products Corporation Tricyclic pyridine N-oxides vasopressin agonists
US6297234B1 (en) 1999-02-04 2001-10-02 American Home Products Corporation Arylthiophene vasopressin agonists
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
BR0208823A (pt) 2001-04-12 2004-03-09 Wyeth Corp Composto, método de tratamento de distúrbios que são remediados ou aliviados pela atividade de agonista de vasopressina em um mamìfero necessitando do mesmo, e, composição farmacêutica
US7064120B2 (en) * 2001-04-12 2006-06-20 Wyeth Tricyclic pyridyl carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
US7326700B2 (en) * 2001-04-12 2008-02-05 Wyeth Cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7202239B2 (en) * 2001-04-12 2007-04-10 Wyeth Cyclohexylphenyl carboxamides tocolytic oxytocin receptor antagonists
DE60222879T2 (de) * 2001-04-12 2008-07-24 Wyeth Cyclohexylphenyl vasopressin agonisten
US7022699B2 (en) 2001-04-12 2006-04-04 Wyeth Cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
US6977254B2 (en) * 2001-04-12 2005-12-20 Wyeth Hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
US7109193B2 (en) 2001-04-12 2006-09-19 Wyeth Tricyclic diazepines tocolytic oxytocin receptor antagonists
US6900200B2 (en) 2001-04-12 2005-05-31 Wyeth Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
EP1632494A1 (de) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonisten
NZ564608A (en) 2005-07-09 2009-09-25 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
AU2007207055B2 (en) * 2006-01-18 2011-06-02 F. Hoffmann-La Roche Ag Thiazoles as 11 beta-HSD1 inhibitors
JP5690286B2 (ja) * 2009-03-04 2015-03-25 イデニク プハルマセウティカルス，インコーポレイテッド ホスホチオフェン及びホスホチアゾールｈｃｖポリメラーゼ阻害剤
WO2010116176A1 (en) 2009-04-09 2010-10-14 Astrazeneca Ab Pyrazolo [4, 5-e] pyrimidine derivative and its use to treat diabetes and obesity
WO2017175000A1 (en) 2016-04-08 2017-10-12 Pulmocide Limited Compounds

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
US4766108A (en) * 1986-12-04 1988-08-23 Smith Kline Beckman Corporation Tyr-Arg-vasopressin antagonists
US5055448A (en) * 1987-06-25 1991-10-08 Medical College Of Ohio Linear derivatives of arginine vasopressin antagonists
EP0382185B1 (de) * 1989-02-10 1994-06-15 Otsuka Pharmaceutical Co., Ltd. Carbostyrilderivate
WO1991005549A1 (en) * 1989-10-20 1991-05-02 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5070187A (en) * 1989-11-03 1991-12-03 Trustees Of Boston University Pharmacologically effective antagonists of arginine-vasopressin
TW199153B (de) * 1990-08-07 1993-02-01 Dtsuka Seiyaku Kk
TW198715B (de) * 1991-04-19 1993-01-21 Dtsuka Seiyaku Kk
EP0533240A3 (en) * 1991-09-16 1993-09-29 Merck & Co. Inc. Substituted amine derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
EP0533242A3 (en) * 1991-09-16 1993-09-15 Merck & Co. Inc. Substituted derivatives of piperazinylcamphorsulfonyl oxytocin antagonists
DE69223573D1 (de) * 1991-09-16 1998-01-29 Merck & Co Inc Hydantoin und Succinimid-substituierte Spiroindanylcamphorsulfonyl als Oxytocin-Antagonisten
US5204349A (en) * 1991-09-16 1993-04-20 Merck & Co., Inc. Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
EP0612319A1 (de) * 1992-08-20 1994-08-31 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclische verbindungen als oxytocin antagonisten und vasopressinantagonisten.
TW270927B (de) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
AU5533894A (en) * 1992-11-25 1994-06-22 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
WO1994014796A1 (fr) * 1992-12-21 1994-07-07 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive de n-(pyridylcarbonyl)benzazepine et son intermediaire
AU6219994A (en) * 1993-03-11 1994-09-26 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) * 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
ZA96298B (en) 1997-07-15
TW342385B (en) 1998-10-11
WO1996022294A1 (en) 1996-07-25
EA199700115A1 (ru) 1997-12-30
AU4770696A (en) 1996-08-07
NZ302119A (en) 2000-02-28
EP0811008A1 (de) 1997-12-10
IL116776A (en) 2000-10-31
CA2210571A1 (en) 1996-07-25
DE69630209D1 (de) 2003-11-06
ES2207672T3 (es) 2004-06-01
EP0811008B1 (de) 2003-10-01
IL116776A0 (en) 1996-05-14
KR19980703098A (ko) 1998-10-15
BR9607153A (pt) 1997-11-11
ATE251166T1 (de) 2003-10-15
AR010195A1 (es) 2000-06-07
HUP9800466A2 (hu) 1998-07-28
CZ224697A3 (cs) 1998-01-14
PT811008E (pt) 2004-02-27
US5654297A (en) 1997-08-05
DE69630209T2 (de) 2004-08-19
MX9705312A (es) 1997-10-31
US5696112A (en) 1997-12-09
HUP9800466A3 (en) 1998-12-28
EA001427B1 (ru) 2001-02-26
JPH10512572A (ja) 1998-12-02
CN1177356A (zh) 1998-03-25
AU716008B2 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
DK0514667T3 (da) Benzazepinderivater som vasopressinantagonister
DK0804438T3 (da) Tricycliske benzazepin-vasopressinantagonister
DE69621225D1 (de) Tricyclische vasopressin antagonisten
BR9606977A (pt) Antagonistas de vasopressina de benzazepina triciclica
ATE381570T1 (de) Trizyclische benzazepin-vasopressin-antagoniste
DK0738150T3 (da) Bicykliske fibrinogene antagonister
BR9710087A (pt) Antagonistas de vasopressina de benzazepina tricíclicos
FI943542L (fi) Trisyklisiä bentsatsepiineja, jotka ovat vasopressiiniantagonisteja
DE69630209D1 (de) Bicyclische benzazepin-derivate als vasopressin-antagonisten
BR9612126A (pt) Derivados de benzazepina
DK1147115T5 (da) Tricycliske benzodiazepiner som vasopressinreceptorantagonister
DE69826487D1 (de) Trizyclische vasopressin agoniste
EP0866705A4 (de) Fibrinogenrezeptorantagonisten
FI960516L (fi) Substituoituja bifenyylisulfonamidiendoteliiniantagonisteja
NO974043D0 (no) Indolderivater som EAA-antagonister
FI960836A7 (fi) Bentsodiatsepiiniyhdisteet, jotka ovat käyttökelpoisia CCK- tai gastriiniantagonisteina
FI943808A7 (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vast avaikuttajina
PT964867E (pt) Antagonistas da taquicinima
KR970013921U (ko) 건축용 다용도 브라켓
HK1003264A (en) Bicyclic benzazepine derivatives as vasopressin antagonists
BR1100543A (pt) antagonistas bicìclicos de fibrinogênio
HK1003892A (en) Tricyclic benzazepine vasopressin antagonists
HK1002959A (en) Tricyclic benzazepine vasopressin antagonists